Related Experiment Video
Updated: Jan 29, 2026
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
Tumor targeting peptides: novel therapeutic strategies in glioblastoma
1Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, United States.
Abstract:
Peptides are a promising new therapeutic approach for glioblastoma with potential for more effective targeting and fewer devastating side effects compared to conventional cancer therapies. With the specificity to target receptors which are uniquely or overexpressed on cancer cells as well as accurately targeting dysregulated signaling pathways, peptides demonstrate a high potential for the treatment of even the most aggressive cancers. By binding to these targets, peptides can be used to deliver drugs, serve as antagonists to various ligands, or, given some inherent anticancer activity, provide additional treatment options alone or in combination therapy. The highly specific targeting capacity of peptides is critical to achieve effective cancer treatment with limited side effects, and in preclinical studies peptides have shown to have both cell and blood brain barrier penetrating capacity. As tumor targeting peptides move beyond the preclinical setting, identification of additional glioblastoma-specific peptide ligands becomes imperative to expand the potential of this encouraging treatment strategy.
Insights
Peptides offer a promising, targeted therapy for glioblastoma, potentially improving treatment efficacy and reducing side effects. Further research into glioblastoma-specific peptide ligands is crucial for advancing this therapeutic strategy.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Glioblastoma presents a significant therapeutic challenge due to its aggressive nature and resistance to conventional treatments.
- Current therapies for glioblastoma often result in severe side effects, necessitating the development of more targeted approaches.
Purpose of the Study:
- To explore the potential of peptide-based therapeutics for glioblastoma treatment.
- To highlight the advantages of peptide specificity in targeting cancer cells and signaling pathways.
- To emphasize the need for identifying novel glioblastoma-specific peptide ligands.
Main Methods:
- Review of preclinical studies on peptide therapeutics for glioblastoma.
- Analysis of peptide mechanisms, including drug delivery, antagonism, and direct anticancer activity.
- Assessment of peptide properties such as cell and blood-brain barrier penetration.
Main Results:
- Peptides demonstrate high specificity for cancer cell receptors and dysregulated pathways.
- Peptides can be utilized for targeted drug delivery, acting as antagonists, or possessing inherent anticancer properties.
- Preclinical data indicate peptides possess both cell and blood-brain barrier penetrating capabilities.
Conclusions:
- Peptides represent a promising therapeutic strategy for glioblastoma, offering targeted action with potentially fewer side effects.
- The development of glioblastoma-specific peptide ligands is essential for expanding the clinical application of this approach.
Related Concept Videos
02:43Peptide Bonds
01:13Therapeutic Index
01:30Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
01:52Persuasion Strategies
01:26Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
01:29Microorganisms in Medicine and Therapeutics